Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIGD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IFT74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100288490 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
INSM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MASP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SF3B3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM68 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNTLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYNC1H1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRCC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507281 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP26A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDUA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on